Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Consulting agrmnt Appointed director
|
Healthcare Triangle, Inc.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
07/14/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
06/29/2023 |
8-K
| Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran... |
06/05/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
03/28/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/21/2023 |
4
| Kizhakevilayil Shibu (Director) has filed a Form 4 on Healthcare Triangle, Inc.
Txns:
| Disposed/sold 200,000 shares
@ $0.001, valued at
$200 |
|
03/21/2023 |
4
| Ramachandran Thyagarajan (CFO) has filed a Form 4 on Healthcare Triangle, Inc.
Txns:
| Disposed/sold 100,000 shares
@ $0.19, valued at
$19k
|
|
03/21/2023 |
4
| Kumar Anand (Vice President, Sales) has filed a Form 4 on Healthcare Triangle, Inc.
Txns:
| Disposed/sold 150,000 shares
@ $0.001, valued at
$150 |
|
03/21/2023 |
4
| Kannappan Lakshmanan (Head of Strategic Partnership) has filed a Form 4 on Healthcare Triangle, Inc.
Txns:
| Disposed/sold 200,000 shares
@ $0.001, valued at
$200 |
|
02/06/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
02/06/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
02/06/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
02/06/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
01/30/2023 |
4
| Rosa David A (Director) has filed a Form 4 on Healthcare Triangle, Inc.
Txns:
| Granted 1 options to buy
@ $0.349, valued at
$0.3 |
|
01/27/2023 |
8-K
| Changes in Registrant's Certifying Accountant, Departure of Directors or Certain Officers; Election of Directors; Appointment... |
12/30/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Registrant's ... |
11/21/2022 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
11/14/2022 |
4/A
| VENKATACHARI SURESH (CEO) has filed a Form 4 on Healthcare Triangle, Inc.
Txns:
| Granted 750,000 shares
@ $0.001, valued at
$750 Granted 25,500,000 shares
@ $0.3, valued at
$7.7M
Granted 6,000 shares
@ $0 |
|
10/19/2022 |
ARS
| Form ARS - Annual Report to Security Holders: |
10/19/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
10/03/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
08/23/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
08/22/2022 |
4
| Rosa David A (Director) has filed a Form 4 on Healthcare Triangle, Inc. |
08/22/2022 |
4
| BJORNSTAD APRIL (Director) has filed a Form 4 on Healthcare Triangle, Inc. |
08/22/2022 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on Healthcare Triangle, Inc. |
08/18/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
08/18/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
08/08/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
07/13/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs:
|
"Form of Securities Purchase Agreement, by and between the Company and the Purchaser",
"Pre-Funded Warrant, by and between the Company and the Purchaser",
"Preferred Investment Option, by and between the Company and the Purchaser",
"Form of Registration Rights Agreement, by and between the Company and the Purchaser",
"Form of Placement Agent Preferred Investment Option",
"Healthcare Triangle Announces $6.5 Million Private Placement PLEASANTON, Calif., July 11, 2022 — Healthcare Triangle Inc., , a leading provider of cloud and data transformation solutions for healthcare and life sciences, today announced that it has entered into a definitive agreement with a single institutional investor for the issuance and sale of 6,097,561 shares of common stock in a private placement. The Company will also issue to the investor unregistered preferred investment options to purchase up to an aggregate of 6,097,561 shares of common stock. The purchase price for one share of common stock and one investment option to purchase one share of common stock is $1.066. The investment options have an exercise price of $1.066 per share, will become exercisable six months following is...",
"Healthcare Triangle Announces Closing of $6.5 Million Private Placement PLEASANTON, Calif., July 13, 2022 — Healthcare Triangle Inc., , a leading provider of cloud and data transformation solutions for healthcare and life sciences, today announced the closing of its previously announced private placement with a single institutional investor for the issuance and sale of 6,097,561 shares of common stock . The Company also issued to the Investor unregistered preferred investment options to purchase up to an aggregate of 6,097,561 shares of common stock. The purchase price for one share of common stock and one Preferred Investment Option to purchase one share of common stock was $1.066. The Preferred Investment Options have an exercise price of $1.066 per share, will become exercisable six mon..." |
|
06/10/2022 |
8-K
| Quarterly results |
05/27/2022 |
8-K
| Quarterly results |
05/16/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
04/01/2022 |
8-K
| Quarterly results |
|
|
|